✨ Free AI Report
NextCure, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview NextCure, Inc.
Research Preview

NextCure, Inc.: Business Overview, Financials & Competitive Analysis

NextCure is a clinical-stage biopharmaceutical company focused on discovering and developing medicines to treat cancer patients who do not respond to, or whose disease progresses on, existing therapies. The company is...

Analyst-debate audio for NextCure, Inc.

AskCyborg analysts argue the bull and bear cases for NextCure, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
NextCure, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
3/ 10Challenged

Cyborg Score thesis

Pre-revenue clinical-stage oncology biotech with promising but unproven assets facing typical R&D and execution...

Read the full analyst-debate transcript →
Industry Clinical-stage oncology immunotherapy and antibody-drug conjugates (ADCs)
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest NextCure, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

NextCure, Inc. Overview

Pro stress-test →

NextCure is a clinical-stage biopharmaceutical company focused on discovering and developing medicines to treat cancer patients who do not respond to, or whose disease progresses on, existing therapies. The company is advancing inventive medicines through targeted therapies including antibody-drug conjugates.

Strategic Profile

Pro stress-test →

The company's lead assets include NC410, a fusion protein of LAIR-2 that demonstrated early clinical activity in colorectal and ovarian cancers in combination with pembrolizumab, and LNCB74, an ADC directed to B7-H4. NextCure is also seeking partners for clinical programs NC525 and NC318, and preclinical non-oncology programs targeting chronic bone diseases and Alzheimer's disease.

Competitive Landscape

Pro stress-test →

NextCure competes within the biotechnology sector alongside peers including BriaCell Therapeutics, Biovie, APOLLOMICS, Carisma Therapeutics, and Portage Biotech. The broader oncology ADC space includes both large pharma (Eli Lilly, Roche, Pfizer) and specialized biotech developers, but NextCure's early-stage pipeline positions it as an emerging competitor rather than a market leader.

Industry Context

NextCure, Inc. operates in Clinical-stage oncology immunotherapy and antibody-drug conjugates (ADCs).

Key facts

Founded: 2015 · Headquarters: Beltsville, Maryland · Employees: 40 · Revenue: $0 · Market cap: $7.3M

What the analysts stress-tested

The top findings that survived the multi-agent debate for NextCure, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when NextCure, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

BriaCell TherapeuticsClinical-stage immunotherapy for cancer→BiovieClinical-stage biopharmaceutical company→APOLLOMICSOncology-focused biotech→Carisma TherapeuticsCell therapy for cancer→

Compare NextCure, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

NextCure, Inc. operates in Clinical-stage oncology immunotherapy and antibody-drug conjugates (ADCs). See how the rest of the sector scores on the Cyborg framework.

Browse Clinical-stage oncology immunotherapy and antibody-drug conjugates (ADCs) research →
NEW · MCP server

Ask your AI assistant about NextCure, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare NextCure, Inc. and its top competitor on Cyborg Score”
“What did NextCure, Inc. do this quarter?”
“Is NextCure, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does NextCure, Inc. do?+
NextCure is a clinical-stage biopharmaceutical company focused on discovering and developing medicines to treat cancer patients who do not respond to, or whose disease progresses on, existing therapies. The company is...
What is NextCure, Inc.'s Cyborg Score?+
NextCure, Inc. has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are NextCure, Inc.'s main competitors?+
Named competitors include BriaCell Therapeutics, Biovie, APOLLOMICS, Carisma Therapeutics. The full competitive landscape is in the AskCyborg report.
How can I get the full NextCure, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the NextCure, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track NextCure, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Phnom Penh Water Supply Authority9ESCO Technologies Inc.9Evolution Mining Limited9CoreWeave, Inc.9Nintendo Co., Ltd.9Waste Management, Inc.9CrowdStrike Holdings, Inc.9SK Hynix Inc.9Kweichow Moutai Co., Ltd.9Apple Inc.8Domino's Pizza, Inc.8Pro-Dex, Inc.8Palladyne AI Corp.8Mo-BRUK S.A.8Kuwait Reinsurance Company K.S.C.P.8Red River Bancshares, Inc.8PTC India Limited8IsoEnergy Ltd.